References 1 Top J, Willems R,

References 1. Top J, Willems R, Bonten M: Emergence of CC17 Enterococcus faecium : from commensal to hospital-adapted pathogen. FEMS Immunol Med Microbiol 2008,52(3):297–308.PubMedCrossRef 2. Arias CA, Murray BE: The rise of the Enterococcus : beyond vancomycin resistance. Nat Rev Microbiol 2012,10(4):266–278.PubMedCentralPubMedCrossRef

3. Grayson ML, Eliopoulos GM, Wennersten CB, Ruoff KL, De Girolami PC, Ferraro MJ, Moellering RC Jr: Increasing resistance to beta-lactam antibiotics among clinical isolates of Enterococcus selleckchem faecium : a 22-year review at one institution. Antimicrob Agents Chemother 1991,35(11):2180–2184.PubMedCentralPubMedCrossRef 4. Jones RN, Sader HS, Erwin ME, Anderson SC: Emerging multiply resistant enterococci among clinical isolates. I. Prevalence data from 97 medical center surveillance study in the GSK2245840 mouse United States. Enterococcus Study Group. Diagn Microbiol Infect Dis 1995,21(2):85–93.PubMedCrossRef 5. Rice LB: Emergence of vancomycin-resistant enterococci. Emerg Infect Dis 2001,7(2):183–187.PubMedCrossRef 6. Uttley AH, Collins CH, Naidoo J, George RC: Vancomycin-resistant enterococci. Lancet 1988,1(8575–6):57–58.PubMedCrossRef 7. Hidron AI, Edwards JR, Patel J, Horan TC, Sievert DM, Pollock DA, Fridkin SK: NHSN annual update: antimicrobial-resistant Linsitinib ic50 pathogens associated with healthcare-associated

infections: annual summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2006–2007. Infect Control Hosp Dichloromethane dehalogenase Epidemiol 2008,29(11):996–1011.PubMedCrossRef 8. Coque TM, Tomayko JF, Ricke SC, Okhyusen PC, Murray BE: Vancomycin-resistant enterococci from nosocomial, community, and animal sources in the United States. Antimicrob Agents Chemother 1996,40(11):2605–2609.PubMedCentralPubMed 9. Rice LB: Antimicrobial resistance in gram-positive bacteria. Am J Med 2006,119(6):S11–19-S62–70. 10. Johnson AP, Uttley AH, Woodford N, George RC: Resistance to vancomycin and teicoplanin: an emerging clinical problem. Clin Microbiol Rev 1990,3(3):280–291.PubMedCentralPubMed 11. Deshpande LM, Fritsche TR, Moet GJ,

Biedenbach DJ, Jones RN: Antimicrobial resistance and molecular epidemiology of vancomycin-resistant enterococci from North America and Europe: a report from the SENTRY antimicrobial surveillance program. Diagn Microbiol Infect Dis 2007,58(2):163–170.PubMedCrossRef 12. Teng F, Kawalec M, Weinstock GM, Hryniewicz W, Murray BE: An Enterococcus faecium secreted antigen, SagA, exhibits broad-spectrum binding to extracellular matrix proteins and appears essential for E. faecium growth. Infect Immun 2003,71(9):5033–5041.PubMedCentralPubMedCrossRef 13. Nallapareddy SR, Singh KV, Murray BE: Contribution of the collagen adhesin Acm to pathogenesis of Enterococcus faecium in experimental endocarditis. Infect Immun 2008,76(9):4120–4128.

Leave a Reply

Your email address will not be published. Required fields are marked *


You may use these HTML tags and attributes: <a href="" title=""> <abbr title=""> <acronym title=""> <b> <blockquote cite=""> <cite> <code> <del datetime=""> <em> <i> <q cite=""> <strike> <strong>